Clinical trials with gene-editing tools to start: Tang Prize laureate
04/22/2018 06:50 PM
Chinese American biologist and 2016 Tang Prize winner in biopharmaceutical science Feng Zhang (張鋒) said Saturday that initial clinical trials using gene-editing technology to help people with genetic diseases are expected to start this year or next.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lai welcomes new Palau envoy, thanks ally for int'l support
09/09/2026 08:47 PM - Society
MOL warns foodpanda over docking couriers' pay for late deliveries
09/09/2026 08:26 PM - Business
TSMC's market share hits record 72.5% in Q2
09/09/2026 08:15 PM - Politics
Taiwan, U.S. must counter China gray-zone pressure: Stanford scholar
09/09/2026 07:50 PM - Business
Taiwan's August exports hit record high on AI-related demand
09/09/2026 07:33 PM